Showing results (61-70 of 125) with videos related to

Sort By:
Pageof 13
European Journal of Nuclear Medicine and Molecular Imaging|January 17, 2025
First real-world clinical experience with [<sup>177</sup>Lu]Lu-PSMA-I&T in patients with metastatic castration-resistant prostate cancer beyond VISION and TheraP criteriaSui Wai Ling, Quido de Lussanet de la Sablonière, Michael Ananta, et al.
BMJ Open|June 22, 2022
Intraperitoneal paclitaxel for patients with primary malignant peritoneal mesothelioma: a phase I/II dose escalation and safety study-INTERACT MESOJob P van Kooten, Michelle V Dietz, Niels A D Guchelaar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 15, 2011
Phase I study of Oral gemcitabine prodrug (LY2334737) alone and in combination with erlotinib in patients with advanced solid tumorsStijn L W Koolen, Petronella O Witteveen, Robert S Jansen, et al.
Clinical Pharmacokinetics|October 28, 2018
Impact of CYP3A4*22 on Pazopanib Pharmacokinetics in Cancer PatientsSander Bins, Alwin D R Huitema, Pim Laven, et al.
Breast (Edinburgh, Scotland)|November 8, 2020
Simplified phenotyping of CYP2D6 for tamoxifen treatment using the N-desmethyl-tamoxifen/ endoxifen ratioClara Inkyung Lee, Siew Kee Low, Ricardo Maldonado, et al.
Neuro-Oncology Advances|October 1, 2021
Generation, characterization, and drug sensitivities of 12 patient-derived IDH1-mutant glioma cell culturesCassandra Verheul, Ioannis Ntafoulis, Trisha V Kers, et al.
Clinical Pharmacology and Therapeutics|October 21, 2021
Effects of the Moderate CYP3A4 Inhibitor Erythromycin on the Pharmacokinetics of Palbociclib: A Randomized Crossover Trial in Patients With Breast CancerLaura Molenaar-Kuijsten, C Louwrens Braal, Stefanie L Groenland, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|July 14, 2022
Feasibility of therapeutic drug monitoring of sorafenib in patients with liver or thyroid cancerNiels A D Guchelaar, Ruben A G van Eerden, Stefanie L Groenland, et al.
Pharmaceutical Research|January 9, 2019
Impact of Older Age on the Exposure of Paclitaxel: a Population Pharmacokinetic StudyMarie-Rose B S Crombag, Aurelia H M de Vries Schultink, Stijn L W Koolen, et al.
CPT: Pharmacometrics & Systems Pharmacology|April 18, 2024
Population pharmacokinetics of intraperitoneal irinotecan and SN-38 in patients with peritoneal metastases from colorectal originPascale C S Rietveld, Sebastiaan D T Sassen, Niels A D Guchelaar, et al.
Pageof 13